Skip to content

Breast Cancer Resiliency Through Exercise Program (B-REP)

Breast Cancer Resiliency Through Exercise Program (B-REP): Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06100263
Acronym
B-REP
Enrollment
75
Registered
2023-10-25
Start date
2024-05-28
Completion date
2026-12-01
Last updated
2026-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Female

Brief summary

The study will use a cross-sectional study design with a follow-up 2-arm randomized controlled trial with that has assessments at baseline, post-intervention (i.e., Week 12), and 3-months post-intervention (i.e., Week 24). The 2 arms are the 12-week intervention and waitlist control among 30 Black breast cancer survivors

Detailed description

14AUG2025- The sample size was updated, and the questionnaire was split into 2 questionnaires, as a planned solution in response to a low accrual 28OCT2025- Amendment was processed to update design and intervention items. The exercise threshold was changed from a 1-repeition maximum (1RM) to a 5-repeptition maximum (5RM). Since the intervention includes functional exercises, so we elected to use a functional strength (5RM) outcome rather than a maximal strength outcome (1RM) to better align with the intervention. The control condition was changed to a waitlist design. A waitlist control is more engaging, and there is a higher likelihood of retaining control participants.

Interventions

guided exercise program for 12 weeks

OTHERControl Arm

Control Arm Waiting List for 24 weeks, then offered a guided exercise program for 12 weeks

Sponsors

University of Michigan Rogel Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Women will be eligible if they meet the following criteria: * self-identify as Black or African American or Afro-Latina/e; * are ≥18 years old; * have a confirmed diagnosis of breast cancer, Stage I to IIIA; * have completed primary active treatment (i.e., surgery, chemotherapy, and radiation) within 5 years prior to study start where concomitant hormonal therapy is acceptable; * are not meeting current cancer-specific resistance exercise guidelines of ≥ 2 times per week; and * are able to speak and understand English.

Exclusion criteria

* metastatic disease; * medical reason that precludes them from increasing current exercise levels; * planned elective surgery during study period; * pregnant or plans to become pregnant during the study period; * plans to move out of United States during the study period; (the rationale for this exclusion is that it will be difficult to conduct the in-person assessments if a participant leaves the United States); * current enrollment in another exercise trial; and/or * inability to pass exercise pre-screening or receive physician consent to increase current physical activity levels.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the exercise program (Retention)up to 24 weeks after start of interventionPercent of patients that complete the intervention
Feasibility of the exercise program (Adherence)12 weeks after start of interventionPercent of patients that complete the exercise sessions
Feasibility of the exercise program (fidelity)12 weeks after start of interventionUpon completion of the trial, a random sample of 10 recorded sessions will be analyzed for fidelity. Research staff who did not conduct the intervention will use a "fidelity checklist" of specific exercises and intervention characteristics (e.g., allowing time for questions, cueing for proper posture and form, etc.) required for each exercise session..
Satisfaction of programup to 24 weeks after start of intervention14-item scale measuring ease of use, convenience, engagement, enjoyment, and privacy elements of the intervention.
Affective attitudeup to 24 weeks after start of intervention36-item scale assessing views, attitude, and experiences in exercise87
Perceived burdenup to 24 weeks after start of interventionSingle item, "Now that you've completed this part of the study, how burdensome or difficult did you find the experience. Select the response that best represents your experience." (1= Very burdensome to 5= Not too burdensome.)
Outcome expectationup to 24 weeks after start of intervention15-item scale assessing physical, social, and self-evaluative outcomes of exercise

Countries

United States

Contacts

CONTACTCancer AnswerLine
CancerAnswerLine@med.umich.edu1-800-865-1125
PRINCIPAL_INVESTIGATORAngela Fong, PhD

University of Michigan Rogel Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026